Trial intelligence / Profile preview

RESCUE: Bashir Catheter for Submassive PE

NCT04248868Phase 3Completed

Sponsor
Thrombolex
Start
Jun 2020
Primary completion
Jun 2022
Countries
1
01

Overview

Phase 3, open-label, single-arm trial in pulmonary embolism (PE), sponsored by Thrombolex. Primary endpoints: Right Ventricle to Left Ventricle Diameter Ratio Difference at 48 hours and Major Bleeding Events at 72 hours. Started Jun 2020; status: completed.

02

Conditions

pulmonary embolism (PE)

Beyond the preview

Go deeper on NCT04248868.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04248868.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call